WJB Capital Group

WJB Capital Group was an institutional broker-dealer based in New York that provided equity research and execution services to institutional investors. The firm was well-regarded for its specialized research teams, which provided extensive coverage of the healthcare, biotechnology, and life sciences sectors. In January 2012, the company abruptly ceased all operations and filed for Chapter 7 bankruptcy protection due to financial insolvency. While the firm was a significant player in providing market analysis for biotech stocks, it did not develop its own therapeutic products or medical technologies. Its closure marked the end of a prominent boutique brokerage that had been active for nearly two decades.